News & Perspective

May 02, 2008

May 02, 2008

Adenovirus-based H5N1 vaccine broadly protective in mice

(CIDRAP News) – An H5N1 influenza vaccine based on a weakened adenovirus was tested successfully in mice and may offer advantages as a tool for combating a human flu pandemic, according to researchers from the Centers for Disease Control and Prevention (CDC) and Purdue University.